Related Experiment Videos
[p53 mutation does not determine prognosis in non-Hodgkin's lymphoma]
M Osada1, C Ishioka, Y Murakawa
1Dept. of Clinical Oncology, Tohoku University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 1, 1997
Abstract:
We studied the clinical significance of the extent of p53 protein expression by immunohistochemical analysis and p53 mutations by functional analysis of p53 in 42 patients with high and intermediate grade of Non-Hodgkin's Lymphoma (NHL). Neither p53 expression nor mutation correlated with short survival or resistance to chemoradiotherapy, implying that p53 mutation is not a prognostic factor in NHL.